Anish Suri
2023
In 2023, Anish Suri earned a total compensation of $1.2M as President and Chief Scientific Officer at Cue Biopharma, a 6% increase compared to previous year.
Compensation breakdown
| Option Awards | $757,826 |
|---|---|
| Salary | $481,486 |
| Other | $3,156 |
| Total | $1,242,468 |
Suri received $757.8K in option awards, accounting for 61% of the total pay in 2023.
Suri also received $481.5K in salary and $3.2K in other compensation.
Rankings
In 2023, Anish Suri's compensation ranked 962nd out of 2,878 executives tracked by ExecPay. In other words, Suri earned more than 66.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 962 out of 2,878 | 67th |
Division Manufacturing | 575 out of 1,582 | 64th |
Major group Chemicals And Allied Products | 394 out of 891 | 56th |
Industry group Drugs | 383 out of 854 | 55th |
Industry Pharmaceutical Preparations | 260 out of 614 | 58th |
Source: SEC filing on April 26, 2024.
Suri's colleagues
We found two more compensation records of executives who worked with Anish Suri at Cue Biopharma in 2023.